Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04460430
Title Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer (NEREA)
Acronym NEREA
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
IPO Lisboa Lisboa 1500-650 Portugal Details
Instituto Portugues de Oncologia de Porto Francisco Gentil, EPE Porto 4200-072 Portugal Details
H. Clínico San Cecilio de Granada Granada Andalucía Spain Details
ICO Badalona Badalona Barcelona Spain Details
Hospital Clínic de Barcelona Barcelona Spain Details
Hospital General de Catalunya Barcelona Spain Details
Hospital Universitari Vall d' Hebron Barcelona Spain Details
Hospital Marina Salud de Denia Denia 03700 Spain Details
Complejo Hospitalario de Jaén Jaén 23007 Spain Details
Hospital Universitari Arnau de Vilanova de Lleida Lleida 25198 Spain Details
Hospital Universitario 12 de octubre Madrid Spain Details
Hospital Universitario Ramon y Cajal Madrid Spain Details
Hospital Son Llatzer Palma de Mallorca Spain Details
Hospital Universitario Virgen del Rocio Sevilla Spain Details
Hospital Virgen de Macarena Sevilla Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field